Tchaikapharma High Quality Medicines AD
THQM | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG1100008074
- LEI:
- 5299003VDHTK75D1JE38
- Country:
- Bulgaria
- Address:
- бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София
- Website:
- https://tchaikapharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Tchaikapharma High Quality Medicines Inc. is the fastest growing pharmaceutical manufacturer operating in Bulgaria. The company is focused on making available contemporary therapeutical solutions on the local, regional and European market in accordance with Good Manufacturing Practice (GMP). Our expertise in fast market penetration is proven by the results we have achieved and continue to achieve for our partners. Our success is built on true respect for the patient and a lasting bond with physicians. Pursuant to its core strategic objectives of transparency and growth, Tchaikapharma goes public in 2015. The company’s shares have been traded successfully on the Bulgarian Stock Exchange since then.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-15 23:00 |
Annual Audited Financial Statements
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
|
English | 47.8 KB | |
| 2024-04-15 23:00 |
Annual Audited Financial Statements
609557-7TH_2023 CONS_BG_signed.xls
|
Bulgarian | 719.5 KB | |
| 2024-04-15 23:00 |
Annual Audited Financial Statements
609559-7TH_2023 CONS_EN_signed.xls
|
Bulgarian | 235.0 KB | |
| 2024-04-15 23:00 |
Annual Report (ESEF)
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
|
Bulgarian | 6.4 MB | |
| 2024-03-26 23:00 |
Interim Report
608037-SPRAVKA_1_IND_GFO_6M.xls
|
Bulgarian | 722.0 KB | |
| 2024-03-26 23:00 |
Regulatory News Service
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
|
Bulgarian | 21.8 MB | |
| 2023-07-12 23:00 |
Regulatory News Service
7TH_2022 CONS_BG.xls
|
Bulgarian | 718.0 KB | |
| 2023-06-07 23:00 |
Interim Report
SPRAVKA_1_IND_GFO_6M_signed.xls
|
Bulgarian | 778.5 KB | |
| 2023-06-07 23:00 |
Foreign Filer Report
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
|
Bulgarian | 37.0 MB | |
| 2022-07-26 23:00 |
Foreign Filer Report
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
|
Bulgarian | 5.7 MB | |
| 2022-07-26 23:00 |
Annual Audited Financial Statements
7TH_2021_signed.xls
|
Bulgarian | 939.0 KB | |
| 2022-07-26 23:00 |
Annual Report (ESEF)
5299003VDHTK75D1JE38-20211231-BG-CON.zip
|
Bulgarian | 3.2 MB | |
| 2022-07-26 23:00 |
Annual Audited Financial Statements
7TH_2021 CONS.xls
|
Bulgarian | 900.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |